CSF2 and rheumatoid arthritis: As TNF-α is a key mediator in RA pathogenesis and anti-TNF therapies have greatly advanced RA treatment (Breedveld and Combe, 2011), progenitors generated under GM-CSF + TNF-α conditions may also function as osteoclast precursors.